|
|
[Back to Documents Menu]
JONAS SALK PUBLICATIONS
Influenza
2. Salk, J., Lavin, G. I., and Francis, T. Jr. --- The antigenic potency of epidemic influenza virus following inactivation by ultraviolet radiation. J. Exp. Med. 72(6): 729-45, 1940.
3. Salk, J. --- Partial purification of the virus of epidemic influenza by adsorption on calcium phosphate. Proc. Soc. Exp. Biol. Med. 46: 709-12, 1941.
4. Francis, T. Jr. and Salk, J. --- A simplified procedure for the concentration and purification of influenza virus. Science 96(2500): 499-500, 1942.
5. Salk, J., Menke, W. J., and Francis, T. Jr. --- Identification of influenza virus type A in current outbreak of respiratory disease. JAMA 124: 93, 1944.
6. Francis, T. Jr., Salk, J., Pearson, H. E., and Brown, P. N. --- Protective effect of vaccination against induced influenza A. Proc. Soc. Exp. Biol. Med. 55: 104-05, 1944.
7. Salk, J., Pearson, H. E., Brown, P. N., and Francis, T. Jr. --- Protective effect of vaccination against induced influenza B. Proc. Soc. Exp. Biol. Med. 55: 106-07, 1944.
8. Francis, T. Jr., Pearson, H. E., Salk, J., and Brown, P. N. --- Immunity in human subjects artificially infected with influenza virus type B. Amer. J. Publ. Hlth. 34(4): 317-34, 1944.
9. Joint Report with Members of the Commission on Influenza, Board for the Investigation and Control of Influenza and Other Epidemic Diseases in the Army, Preventive Medicine Service, Office of the Surgeon General, United States Army. --- A clinical evaluation of vaccination against influenza. JAMA 124: 982-85, 1944.
10. Salk, J. --- A simplified procedure for titrating hemagglutinating capacity of influenza virus and the corresponding antibody. J. Immunol. 49(2): 87-98, 1944.
11. Salk, J. --- The immunizing effect of calcium phosphate adsorbed influenza virus. Science 101(2614): 122-24, 1945.
12. Francis, T. Jr., Salk, J., Pearson, H. E., and Brown, P. N. --- Protective effect of vaccination against induced influenza A. J. Clin. Invest. 24(4): 536-46, 1945.
13. Francis, T. Jr., Salk, J., Pearson, H. E., and Brown, P. N. --- Protective effect of vaccination against induced influenza B. J. Clin. Invest. 24(4): 547-53, 1945.
14. Salk, J., Menke, W. J. Jr., and Francis, T. Jr. --- A clinical, epidemiological and immunological evaluation of vaccination against epidemic influenza. Amer. J. Hyg. 42(1): 57-93, 1945.
15. Salk, J., Pearson, H. E., Brown, P. N., Smyth, C. J., and Francis, T. Jr. --- Immunization against influenza with observations during an epidemic of influenza A one year after vaccination. Amer. J. Hyg. 42(3): 307-22, 1945.
16. Salk, J. --- Laboratory methods used for the recognition of influenza. Bull. U.S. Army Med. Dept. 5(1): 32-36, 1946.
17. Francis, T. Jr., Salk, J., and Brace, W. M. --- The protective effect of vaccination against epidemic influenza B. JAMA 131: 275-78, 1946.
17a. Salk, J. --- Influenza in Europe during the winter of 1945-46. J. Bacteriol. 51: 632, 1946.
18. Salk, J. and Francis, T. Jr. --- Immunization against influenza. Ann. Int. Med. 25(3): 443-52, 1946.
19. Francis, T. Jr. and Salk, J. --- A consideration of vaccination against influenza. Trans. Assn. Amer. Physician 59: 197-204, 1946.
20. Salk, J. --- Variation in influenza viruses. A study of heat stability of the red cell agglutinating factor. Proc. Soc. Exp. Biol. Med. 63: 134-39, 1946.
21. Salk, J. --- Effect of formalin in increasing heat stability of influenza virus hemagglutinin. Proc. Soc. Exp. Biol. Med. 63: 140-43, 1946.
22. Salk, J. --- The control of influenza by immunization. The J. Lancet (Minn.) 67(1): 18-23, 1947.
23. Salk, J. --- Reactions to influenza virus vaccines. JAMA 134(4): 393, 1947.
24. Blaskovic, D. and Salk, J. --- A method applicable to the standardization of influenza virus vaccines. Proc. Soc. Exp. Biol. Med. 65: 352-59, 1947.
25. Francis, T. Jr., Salk, J., and Quilligan, J. J. Jr. --- Experience with vaccination against influenza in the spring of 1947. Amer. J. Publ. Hlth. 37(8): 1013-16, 1947.
26. Salk, J. --- Influenza. In Handbook of Communicable Diseases, 2nd Ed., F. H. Top and Collaborators (St. Louis: C. V. Mosby & Co., 1947), pp. 626-45.
27. Salk, J. --- Studies on the antigenicity, in man, of calcium phosphate adsorbed influenza virus; with comments on the questions of dose of virus needed in vaccines for human use. J. Immunol. 57(4): 301-21, 1947.
28. Salk, J. --- Reactions to concentrated influenza virus vaccines. J. Immunol. 58(4): 369-95, 1948.
29. Salk, J. --- A plastic plate for use in tests involving virus hemagglutination and other similar reactions. Science 108(2818): 749, 1948.
29a. Salk, J. --- Studies on calcium phosphate adsorbed influenza virus. In Report of the Proceedings of the Fourth International Congress of Microbiology (Copenhagen, l949), p. 298.
30. Salk, J. and Suriano, P. C. --- Importance of antigenic composition of influenza virus vaccine in protecting against the natural disease. Observations during the winter of 1947-48. Amer. J. Publ. Hlth. 39(3): 345-55, 1949.
31. Salk, J., Laurent, A. M., and McGinnis, R. C. --- Differences in antigenic capacity among influenza virus strains. Fed. Proc. 8(1), March 1949.
31a. Salk, J. and Lynch, M. P. --- Unusual serological findings in a group of cases of pneumococcal pneumonia associated with the presence of influenza virus in the sputum. J. Clin. Invest. 28(4): 808, 1949.
32. Salk, J. --- Viral and rickettsial infections of the lung. Comments on the problem of specific therapy. Penn. Med. J. 52: 1650-52, 1949.
33. Salk, J. and Youngner, J. S. --- Antibody in yolk of eggs and in serum from hens inoculated with viruses of influenza and poliomyelitis. Fed. Proc. 9(l): 391, 1950.
35a. Salk, J., Bailey, M. L., and Laurent, A. M --- A safe immunologic adjuvant for enhancing the height and persistence of antibody response to influenza virus vaccines in man. J. Clin. Invest. 30(6): 699 (abstract), 1951.
36. Salk, J., Laurent A. M, and Bailey, M. L. --- Direction of research on vaccination against influenza--new studies with immunological adjuvants. Amer. J. Publ. Hlth. 41(6): 669-77, 1951.
39. Salk, J. --- A critique of serologic methods for the study of influenza viruses. Archiv. Gesamte Virusfors. 4(4): 476-84, 1951.
42. Salk, J. and Laurent, A. M. --- The use of adjuvants in studies on influenza immunization. I. Measurements in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions. J. Exp. Med. 95(5): 429-47, 1952.
43. Salk, J., Bailey, M. L., and Laurent, A. M. --- The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water-in-oil emulsion. Amer. J. Hyg. 55(3): 439-56, 1952.
46. Salk, J. --- An interpretation of the significance of the influenza virus variation for the development of an effective vaccine. Bull. N.Y. Acad. Med. 28(11): 748-65, 1952.
51. Salk, J., Contakos, M., Laurent, A. M., Sorensen, M., Rapalski, A. J., Simmons, I. H., and Sandberg, H. --- Use of adjuvants in studies on influenza immunization. 3. Degree of persistence of antibody in human subjects two years after vaccination. JAMA 151(14): 1169-75, 1953.
53. Salk, J. --- Principles of immunization as applied to poliomyelitis and influenza. Amer. J. Publ. Hlth. 43(11): 1384-98, 1953.
76. Salk, J. and Rapalski, A. J. --- Evaluation of influenza vaccine in an explosive epidemic of mixed etiology. U.S. Armed Forces Med. J. 9(4): 469- 78, 1958.
97. Salk, J. and Salk, D. --- Control of influenza and poliomyelitis with killed virus vaccines. Science 195(4281): 834-47, 1977.
|
|
|